Full Day Live Stream - Room W196

Thursday, April 24

Registration and Networking Breakfast
7:30-9:00 AM | W190 and W194

Welcome
9:00-9:15 AM

Spotlight Session 1: Bristol Myers Squibb
9:15-10:00 AM

• Introduction
• Michael Pourdehnad – Senior Vice President, Head of Early Clinical Development, Hematology, Oncology and Cell Therapy
• Q&A

Break
10:00-10:15 AM | W196 Foyer

Spotlight Session 2: Pfizer
10:15-11:00 AM

• Introduction
• Megan O'Meara – Interim Chief Development Officer and Head of Early Stage Development, Pfizer Oncology‍
• Discussion / Q&A

Break
11:00-11:15 AM | W196 Foyer

Spotlight Session 3: Johnson & Johnson Innovative Medicine
11:15 AM-12:00 PM

• Introduction
• Yusri A. Elsayed – Senior Vice President, Head of Oncology R&D
• Discussion / Q&A

Networking Lunch
12:00-1:30 PM | W190 and W194

Panel Discussion A
12:15-1:15 PM

• Next Generation Bispecifics | Moderator: Andrew Berens and Daina Graybosch - Leerink Partners | Panelists: Craig Gibbs, AsherBio; Jeff Infante, Johnson & Johnson Innovative Medicine; Bill Lundberg, Merus

Spotlight Session 4: Bayer Pharmaceuticals
1:30-2:15 PM

• Introduction
• Dominik Ruettinger – Global Head Research and Early Development Oncology
• Discussion / Q&A

Break
2:15-2:30 PM | W196 Foyer

Spotlight Session 5: AstraZeneca
2:30-3:15 PM

• Introduction
• Susan M. Galbraith – Executive Vice-President, Oncology Research & Development
• Discussion / Q&A

Break
3:15-3:30 PM | W196 Foyer

Spotlight Session 6: Eli Lilly & Company
3:30-4:15 PM

• Introduction
• Arjun Balar – Senior Vice President, Global Clinical Development
• Discussion / Q&A

Break
4:15-4:30 PM | W196 Foyer

Showcase Session 1
4:30-5:30 PM

• Introduction
• Crossbow Therapeutics - Briggs Morrison - Chief Executive Officer
• Aethon Therapeutics - Sean Toenjes - Executive Director of Chemistry & Innovation
• Zymeworks - Lucas Donigian - Vice President, Business & Commercial Development
• Discussion / Q&A

Concurrent Panel Discussion B-C
5:45-6:45 PM

• Drugging the Undruggable / Transcription Factors | Moderator: Jonathan Chang, Leerink Partners | Panelists: Liron Bar-Peled, Massachusetts General Hospital; NickGlover, MycRX; Rami Rahal, MPM BioImpact; Peter Smith, Remix Therapeutics

‍

Reception
7:00-9:00 PM | Regency Ballroom, Hyatt Regency McCormick Place

‍